Mohammad Abufaraj

Dr. Mohammad Abufaraj

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in European Urology Focus
Verified
Journal Article
Closed access
MAMohammad Abufaraj
Mohammad Abufaraj
TXTianlin Xu
Tianlin Xu
CCChao Cao
Chao Cao
TWThomas Waldhoer
Thomas Waldhoer
CSChristian Seitz
Christian Seitz
SSShahrokh F. Shariat
Shahrokh F. Shariat

18 July 2019 in World Journal of Urology
Verified
Journal Article
Closed access
FJFlorian Janisch
Florian Janisch
SSShahrokh F. Shariat
Shahrokh F. Shariat
PBPascal Baltzer
Pascal Baltzer
HFHarun Fajkovic
Harun Fajkovic
SKShoji Kimura
Shoji Kimura
MAMohammad Abufaraj
Mohammad Abufaraj

1 April 2018 in European Urology
Verified
Journal Article
Closed access
MAMohammad Abufaraj
Mohammad Abufaraj
GDGuido Dalbagni
Guido Dalbagni
SDSiamak Daneshmand
Siamak Daneshmand
SHSimon Horenblas
Simon Horenblas
AKAshish M. Kamat
Ashish M. Kamat
SSShahrokh F. Shariat
Shahrokh F. Shariat

16 November 2017 in World Journal of Urology
Verified
Journal Article
Open access
PDF file
Andrea MariAndrea Mari
Andrea Mari
RCRiccardo Campi
Riccardo Campi
RTRiccardo Tellini
Riccardo Tellini
GGGiorgio Gandaglia
Giorgio Gandaglia
SASimone Albisinni
Simone Albisinni
SSShahrokh F. Shariat
Shahrokh F. Shariat
Purpose To review the currently available literature reporting the patterns of recurrence and their predictive factors after open radical cystectomy (RC) for bladder cancer. Methods A review of the literature was performed using the MEDLINE, Scopus and Web of Sciences databases from January 1997 to May 2017. The PRISMA guidelines were followed for the conduct of the study. Results Local recurrence rate ranges between 30 and 54%. Distant recurrence is not often standardized and is reported in up to 50% of cases. The overall 5-year recurrence-free survival rates from 58 to 81%. The mean follow-up of studies included in the analysis ranged from 18 to 350 months. Details on the most important demographic and epidemiological, clinical, histologic and pathologic predictors of recurrence after radical cystectomy are provided through an evidence-based approach. The impact of the extension of lymph node dissection on recurrence after RC is investigated. Conclusions A correct prognostic assessment is essential for patients undergoing radical cystectomy for bladder cancer, thereby potentially improving their oncologic outcomes.

1 September 2018 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
MVMihai Dorin Vartolomei
Mihai Dorin Vartolomei
DPDaniel Porav-Hodade
Daniel Porav-Hodade
MFMatteo Ferro
Matteo Ferro
RMRomain Mathieu
Romain Mathieu
MAMohammad Abufaraj
Mohammad Abufaraj
SSShahrokh F. Shariat
Shahrokh F. Shariat

1 April 2019 in European Urology
Verified
Journal Article
Closed access
MAMohammad Abufaraj
Mohammad Abufaraj
BFBeat Foerster
Beat Foerster
ESEva Schernhammer
Eva Schernhammer
MMMarco Moschini
Marco Moschini
SKShoji Kimura
Shoji Kimura
SSShahrokh F. Shariat
Shahrokh F. Shariat